SPCs — We Wait In Vain For Clarity From Europe
In Europe, patent holders can obtain compensation for regulatory delays in bringing a new medicinal product to market via the award of a supplementary protection certificate ("SPC"), which provides a limited...To view the full article, register now.
Already a subscriber? Click here to view full article